ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

OPKO Health, Inc. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 58 studies whose lead sponsor is OPKO Health, Inc. or one of 2 companies grouped under it. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 6, 2026.

Our grouping of 3 registry names, not the registry’s. See them and correct one ↓

Compare OPKO Health with Merck and Moderna →

Pipeline: 5 programs

Each counted once: 5 with a study OPKO Health, Inc. leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of OPKO Health, Inc.’s own registered studies; OPKO Health, Inc.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs OPKO Health, Inc.’s studies test, most open studies first — 9 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

2 of OPKO Health, Inc.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. 1S
  12. 1O
  13. N

Add all 2 to your calendar (.ics) → With an account.

All 58 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now610%
  • Completed4272%
  • Stopped early1017%Terminated 8 · Withdrawn 2

Phase

  • Phase 226
  • Phase 121
  • Phase 310
  • Phase 41

Where

  • United States40
  • Canada9
  • Israel8
  • Spain7
  • United Kingdom4
  • Greece4

Over the years

  1. 07
  2. 08
  3. 509
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 426

By the year each study started; 7 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to OPKO Health, Inc.

  • OPKO Health, Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    49 studies
  • OPKO IP Holdings II, Inc.
    Acquired — became part of OPKO Health, Inc., Mar 4, 2013 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • ModeX Therapeutics, An OPKO Health Company
    Acquired — became part of OPKO Health, Inc., May 9, 2022 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →

Focus areas

Conditions OPKO Health, Inc. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 58. Browse all 58 →